Altamira Therapeutics Ltd...
(CYTO)
undefined
undefined%
At close: undefined
0.49
11.61%
After-hours Dec 13, 2024, 07:59 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 617.41K | 15.39K | 984.19K | 11.26M | 1.38M | 5.39M | 14.97M | 32.44M | 50.24M | 56.93M | 23.87M | 63.97K | 752.87K |
| Short-Term Investments | - | - | - | - | - | - | - | - | - | - | - | - | 72.85K |
| Long-Term Investments | 2.50M | 194.26K | 199.10K | 20.00K | - | - | - | - | - | 2.60M | - | - | - |
| Other Long-Term Assets | - | -4.53M | -15.08M | -9.16M | 20.00K | 242.87K | 76.71K | 114.78K | 38.00K | -2.60M | - | -482.02K | - |
| Receivables | 74.82K | 6.53K | 21.75K | - | - | - | - | 216.63K | 651.00K | 91.30K | 73.58K | - | 101.24K |
| Inventory | - | 11.64K | 839.22K | -358.17M | -988.49M | -80.04K | -79.84K | - | -465.67K | 226.93K | 596.31K | 194.75K | - |
| Other Current Assets | 530.92K | 979.44K | 2.25M | 288.11K | 733.89K | 431.32K | 732.75K | 1.03M | 646.67K | 716.40K | 634.34K | 203.98K | 77.88K |
| Total Current Assets | 1.22M | 1.77M | 3.76M | 11.62M | 2.37M | 6.06M | 15.87M | 33.69M | 51.07M | 57.74M | 24.57M | 383.74K | 1.00M |
| Property-Plant & Equipment | 80.11K | 445.83K | 564.72K | 46.64K | 66.67K | 33.90K | 252.90K | 369.29K | 223.00K | 235.00K | 195.91K | 124.50K | 1.99K |
| Goodwill & Intangibles | 3.89M | 3.89M | 14.31M | 9.12M | 6.77M | 3.54M | 1.63M | 1.48M | 1.48M | 1.48M | 1.48M | 357.52K | 357.52K |
| Total Long-Term Assets | 6.47M | 4.53M | 15.08M | 9.18M | 6.85M | 3.81M | 1.96M | 1.97M | 1.74M | 1.75M | 1.68M | 482.02K | 359.51K |
| Total Assets | 7.69M | 6.30M | 18.84M | 20.80M | 9.23M | 9.88M | 17.83M | 35.66M | 52.81M | 59.49M | 26.25M | 865.76K | 1.36M |
| Account Payables | 413.11K | 4.77M | 3.54M | 722.27K | 906.50K | 1.81M | 1.03M | 1.73M | 965.47K | 3.14M | 946.22K | 410.06K | 145.43K |
| Deferred Revenue | - | - | - | 1.43M | - | -25.89K | -168.26K | - | - | - | - | - | - |
| Short-Term Debt | 99.66K | 5.99M | 114.25K | 523.92K | - | 1.44M | 4.54M | 2.21M | - | - | 13.71M | - | - |
| Other Current Liabilities | 376.14K | 2.12M | 1.20M | 1.78M | 1.37M | 1.32M | 4.85M | 5.01M | 5.20M | 1.30M | 1.91M | 457.08K | 567.81K |
| Total Current Liabilities | 888.91K | 12.88M | 4.86M | 3.03M | 2.28M | 4.56M | 10.43M | 8.96M | 6.17M | 4.44M | 16.56M | 867.14K | 713.24K |
| Long-Term Debt | - | 343.63K | 461.49K | - | - | - | 5.58M | 10.15M | - | - | - | - | - |
| Other Long-Term Liabilities | 346.63K | 1.39M | 812.04K | 873.69K | 764.80K | 1.32M | 3.98M | 2.41M | 1.58M | 1.41M | 328.34K | 242.65K | 178.52K |
| Total Long-Term Liabilities | 346.63K | 1.74M | 1.27M | 999.56K | 911.95K | 1.66M | 9.56M | 12.56M | 1.90M | 1.77M | 655.98K | 242.65K | 178.52K |
| Total Liabilities | 1.24M | 14.62M | 6.13M | 4.03M | 3.19M | 6.23M | 19.99M | 21.52M | 8.07M | 6.21M | 17.22M | 1.11M | 891.77K |
| Total Debt | 99.66K | 6.33M | 575.74K | 523.92K | - | 1.44M | 10.13M | 12.36M | - | - | 13.71M | - | - |
| Common Stock | 2.65K | 236.01K | 149.64K | 114.17K | 1.65M | 710.34K | 19.35M | 13.73M | 13.72M | 11.60M | 6.49M | 4.63M | 4.63M |
| Retained Earnings | -18.05M | -201.43M | -176.02M | -160.64M | -152.78M | -146.30M | -136.13M | -112.34M | -81.58M | -52.13M | -33.12M | -18.24M | -13.64M |
| Comprehensive Income | 177.58K | 258.04K | 62.07K | 61.30K | -27.57K | -44.01K | -33.05K | -83.54K | -64.00K | -51.00K | 53.99K | 22.27K | - |
| Shareholders Equity | 6.46M | -8.31M | 12.70M | 16.77M | 6.04M | 3.65M | -2.16M | 14.14M | 44.74M | 53.28M | 9.03M | -244.03K | 472.58K |
| Total Investments | 2.50M | 194.26K | 199.10K | 20.00K | - | - | - | - | - | 2.60M | - | - | 72.85K |